General Information of Drug Therapeutic Target (DTT) (ID: TTH91NV)

DTT Name HUMAN C-C chemokine receptor 5 (CCR5)
Synonyms HIV-1 fusion coreceptor; HIV-1 fusion co-receptor; Chemokine receptor CCR5; CMKBR5; CHEMR13; CD195 antigen; CD195; CCR-5; CC-CKR-5; C-C CKR-5
Gene Name CCR5
BioChemical Class
GPCR rhodopsin
UniProt ID
CCR5_HUMAN
TTD ID
T97747
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MDYQVSSPIYDINYYTSEPCQKINVKQIAARLLPPLYSLVFIFGFVGNMLVILILINCKR
LKSMTDIYLLNLAISDLFFLLTVPFWAHYAAAQWDFGNTMCQLLTGLYFIGFFSGIFFII
LLTIDRYLAVVHAVFALKARTVTFGVVTSVITWVVAVFASLPGIIFTRSQKEGLHYTCSS
HFPYSQYQFWKNFQTLKIVILGLVLPLLVMVICYSGILKTLLRCRNEKKRHRAVRLIFTI
MIVYFLFWAPYNIVLLLNTFQEFFGLNNCSSSNRLDQAMQVTETLGMTHCCINPIIYAFV
GEKFRNYLLVFFQKHIAKRFCKCCSIFQQEAPERASSVYTRSTGEQEISVGL
Function
May play a role in the control of granulocytic lineage proliferation or differentiation. Receptor for a number of inflammatory CC-chemokines including CCL3/MIP-1-alpha, CCL4/MIP-1-beta and RANTES and subsequently transduces a signal by increasing the intracellular calcium ion level.
KEGG Pathway
Viral life cycle - HIV-1 (hsa03250 )
Cytokine-cytokine receptor interaction (hsa04060 )
Viral protein interaction with cytokine and cytokine receptor (hsa04061 )
Chemokine signaling pathway (hsa04062 )
Endocytosis (hsa04144 )
Toxoplasmosis (hsa05145 )
Human cytomegalovirus infection (hsa05163 )
Kaposi sarcoma-associated herpesvirus infection (hsa05167 )
Human immunodeficiency virus 1 infection (hsa05170 )
Viral carcinogenesis (hsa05203 )
Reactome Pathway
Chemokine receptors bind chemokines (R-HSA-380108 )
G alpha (i) signalling events (R-HSA-418594 )
Interleukin-10 signaling (R-HSA-6783783 )
Binding and entry of HIV virion (R-HSA-173107 )

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DTT
1 Drugs in Phase 2 Trial Targeting This DTT
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leronlimab DMMQ6VT Coronavirus Disease 2019 (COVID-19) 1D6Y Phase 2 Trial [1]
------------------------------------------------------------------------------------

References

1 Disruption of the CCL5/RANTES-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19